Pii has broad knowledge and technical experience in dosage form development and GMP manufacturing. Pii is able to provide clients with a wide range of options to develop small molecules into quality pharmaceutical products. The key to our success is being able to provide a flexible approach for the client whether it is a step by step approach to development work or simply the transfer of a product into development at late stage.
Over the years Pii has worked with over 400 NCEs having a range of physico-chemical characteristics. |
Pii’s highly trained scientific team has extensive experience working with a variety of drug substances, with a range of physiochemical characteristics, including:
- poorly aqueous soluble drugs
- highly potent and cytotoxic drugs
Pii’s development capabilities include modified and extended release formulations. For poorly soluble compounds, Pii offers a variety of bioavailability enhancement technologies, including solid dispersion development and lipid-or micro/nano-based emulsions.
Dosage Forms
|
|
Pre-Formulation Services
Preformulation protocols are designed to meet each client’s requirements.
|
|